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TETRACYCLINE can be detected in the tissues by its bright yellow fluorescence
in ultra-violet light. Using this method it has been shown that, within a few
minutes after parenteral administration of the drug, it is distributed to all the
tissues ofthe body except the central nervous system. The highest concentrations
are present in the liver, kidneys and bones. At 24 hours the drug has been
excreted from all the tissues except the bones where it persists indefinitely in areas
of new bone formation (Bottiger, 1955; Harris, 1960; Carroll and Tapp, 1965).
In 1957 Rail and his associates, while studying the effects of a fluorescent
riboflavin antagonist on metastases from carcinoma of the breast in humans,
observed at necropsy on patients who had not received the riboflavin antagonist
that some other fluorescent material was present in the tumour tissue. Examina-
tion of the case records showed that the patients had been given tetracycline
some weeks previously. Subsequently these workers reported that a variety of
tumours in experimental animals take up and retain tetracycline. Their findings
in tumours in man and experimental animals have since been confirmed on many
occasions (McLeay, 1958; Phillips, Cobb, Richards, Rhodes, Loehrer and Ritchie,
1960; Vassar, Saunders and Culling, 1960; Malek and Kolc, 1960; Milch,
Tobie and Robinson, 1961; McLeay and Walske, 1962; Riley, 1963).
The exact site at which tetracycline is localised in the tumours has been the
subject of considerable controversy. Most workers consider that tetracycline is
localised only in viable tumour tissue and is absent from necrotic areas (Rail,
Loo, Lane and Kelly, 1957; Phillips et al., 1960; McLeay and Walske, 1962).
On the other hand Vassar et al. (1960) said that there was no tetracycline in live
tumour tissue in human patients, and found it only in macrophages and tissue
debris. Very recently Machado, Zaidman, Gerstein, Lichtenberg and Gray (1964)
reported that tetracycline was not retained by live cells in transplants of sarcoma-
37 in mice but that it was present in the necrotic tumour cells.
Inthe present studies the uptake andretention ofthe drug has beeninvestigated
in a number of different experimental tumours. Relatively large doses have been
used because the subsequent localisation by fluorescent methods is easier.
MATERIALS AND METHODS
The production of tumours
Squamous tumours.-Tumours were produced on both ears of 18 adult rabbits
by the biweekly application of 5 drops of a 1% solution of 9,10-dimethyl-
1,2-benzanthracene (:DMBA) in xylene (Berenblum, 1945).
Ovarian tumours.-Tumours were produced in 12 black hooded rats and in
6 albino rats of the Wistar strain by transplanting one ovary into the spleen and
excising the remaining ovary (Biskind and Biskind, 1944).TETRACYCLINE FLUORESCENCE
Mammary tumours.-Tumours were produced in 24 female albino rats of the
Wistar and Sprague-Dawley strains by the administration of 9,10-dimethyl-
1,2-benzanthracene (DMBA) in corn oil (Huggins, Briziarelli and Sutton, 1959).
The Wistar rats were given the drug by intra-gastric tube in a dose of 10 mg.
twice weekly for 3 weeks beginning when the rats were 50 days old. The Sprague-
Dawley rats were given a single dose of 50 mg. at 50 days of age.
Leukaemia.-Six of the Wistar rats treated with DMBA also developed
leukaemia at about the same time that the breast tumours became obvious. A
similar finding was reported by Dao (1962) in two out of 100 Sprague-Dawley
rats which had received a single dose of 30 mg. of DMBA.
Tetracycline administration
Tetracycline hydrochloride was given to the rabbits by intramuscular injection
in a dose of 5 mg. per 100 g. body weight. The rats received intramuscular or
intraperitoneal injections of 15 mg. per 100 g. body weight or an intravenous
injection of5 mg. per 100 g. bodyweight. Some animals received a single injection
of the drug while others were given four doses at daily intervals. Maximum
concentrations of tetracycline are found in the tissues at between one and four
hours after the injection. Excretion ofthe drug occurs rapidly so that at 24 hours
very little is found in the body except in the bones. If tetracycline is found in
other organs at 48 hours this can be regarded as indicating abnormal retention
by the tissues of that organ.
In the present experiments the uptake of tetracycline by the tumours was
investigated in animals killed between one and 4 hours after a single injection of
tetracycline. The retention of the drug by the tumours was studied in animals
killed at times from 2 to 28 days after the last of four injections of tetracycline.
Histological methods
Fresh frozen sections cut at 5 It were examined microscopically unstained in
ultra-violet light. Corresponding frozen sections were stained with haematoxylin
and eosin. Paraffin blocks were also prepared from adjacent tissue, and sections
cut at 5 It were stained with haematoxylin and eosin.
RESULTS
Squamous Tumours
Small warty growths about 1 cm. in diameter became obvious on the ears of
the rabbits between 3 and 4 months after the first application of DMBA. There
were usually three or four tumours on each ear. Some ofthese tumours increased
rapidly in size over the next 4 weeks with destruction ofthe greater part ofthe ear.
Ulceration occurred in many of the tumours and secondary infection of the ulcer-
ated area caused further damage to the ear. A good deal of keratin was present
on the surface of some of the tumours.
Although local invasion was marked there was no spread to the local lymph
nodes or to the rest of the body.
On histological examination the early lesions were superficial and had a
papillomatous growth of squamous epithelium which was heavily keratinised.
The large invasive tumours which developed later had the appearances of fairly
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well differentiated squamous carcinoma. Cell nests containing keratin were
present (Fig. 1). In some of the cell nests there were collections of polymorphs
and necrotic tumour cells between the layers ofkeratin, and in other cell nests the
whole central mass was a mixture of polymorphs, dead tumour cells and debris.
In the non-kertinised parts of the tumour there was also necrosis in the centre of
some of the tumour masses (Fig. 2). Invasion of the deeper tissues had occurred,
and, although the cartilage appeared to be fairly resistant to invasion, it had been
eroded in some places (Fig. 3). Destruction of the cartilage was particularly
marked where ulceration and secondary infection was present.
Tetracycline studie8
There did not appear to be any difference in the amount of tetracycline taken
up by the tumours in animals given the 4 day course of tetracycline and in those
given only a single dose. The following description applies to both groups.
Only small amounts oftetracycline were taken up by the live tumour cells and
even less by the stroma of the tumour. High concentrations were present in thin
bands in some keratinised areas (Fig. 4). This was particularly noticeable when
the animals had received multiple injections of tetracycline. Much higher
concentrations were found in the necrotic cells of the deeper parts of the tumours
(Fig. 4) and in the necrotic material in the cell nests (Fig. 5). A good deal of
tetracycline was also found in necrotic granulation tissue at the ulcerated surfaces
of the tumours (Fig. 6).
Large amounts of tetracycline were retained in necrotic areas and persisted
there for at least 4 'weeks after the last injection of the drug. A similar retention
oftetracycline was also observed in bands ofkeratin. On the other hand the small
EXPLANATION OF PLATES
FIG. 1.-Fairly well differentiated squamous carcinoma with a cell nest containing keratin.
H.&E. x125.
FIG. 2. Necrosis in the centre of a tumour mass in a non-keratinised ]Part of the tumour.
H. &E. x125.
FIG. 3.-Invasion of the deeper tissues and erosion of the cartilage by the tumour. H. & E.
x 125.
FIG. 4. High concentrations of tetracyline in thin bands in a keratinised part of the tumour
and in necrotic cells at the top of the photograph. Unstained frozen section in ultra-violet
light. x 80.
FIG. 5. High concentrations of tetracycline in necrotic material in cell nests. Unstained
frozen section in ultra-violet light. x 80.
FIG. 6. High concentrations of tetracycline at an ulcerated surface. Particularly high
concentrations are present in the necrotic granulation tissue (junction of left two thirds
and right one third of the photograph). Unstained frozen section in ultra-violet light.
>< 160.
FIG. 7. A high power view ofthe cells in a tumour which was predominently of the granulosa-
cell type. H. & E. x 500.
FIG. 8. Autofluorescence due to lipofuscin pigment in the stroma of an ovarian tumour.
Unstained frozen section in ultra-violet light. x 80.
FIG. 9.-Adenocarcinoma ofthemammary gland ofa rat treated with DMBA. H. & E. x 50.
FIG. 10.-Similar areas ofnecrosis were present in all the mammary tumours. H. & E. x 50.
FIG. 11.-Tetracycline in a necrotic area of a tumour from an animal killed 3 weeks after the
administration of this substance. Unstained frozen section in ultra-violet light. x 50.
FIG. 12. The immature white blood cells have replaced the normal liver parenchyma in
some areas. H. & E. x 500.
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amounts of tetracycline present in the tumour cells and stroma disappeared as
the drug was excreted from the rest of the body and there was no evidence that
tetracyclinie was retained in tumour cells which had not undergone necrosis.
Ovarian Tumours
The tumours that developed in the spleen were examined between 6 and 24
months after transplanting the ovary. Thev were solid tumours, varying between
one and four centimeters in diameter, the largest weighing between 40 and 50 g.
The colour varied, being mostly greyish-brown but scattered yellowish areas were
also present. The tumour had invaded and replaced the greater part ofthe spleen
but there was no invasion of neighbouring organs or spread to other parts of the
body.
Histologically the tumours were predominantly of the granulosa-cell type,
consisting of large polyhedral-shaped cells arranged in sheets or coarse trabeculae
(Fig. 7). The cytoplasm of the cells varied; usually it was clear and pale but
sometimes it was foamy and eosinophilic. The nuclei were round with a stippled
chromatin pattern. Some tumours were of mixed type and had a lobular pattern
with spindle-shaped cells resembling those found in thecomas between groups of
granulosa cells. Granules of a lipfuscin pigment were present amongst the
spindle-shaped cells. There was no necrosis in the tumours.
7'etracycline studies
Tetracycline was taken up in small amounts by the tumour cells of both the
granulosa and the coma type but the uptake by the tumour cells was not higher
than by normal ovarian tissue. The tetracycline gradually disappeared from these
cells during the 48 hours after the injection of the drug. There was Ino retention
of tetracycline by the tumour.
A substance which gave a dull orange-yellow autofluorescence, quite distinct
from the bright yellow fluorescence of tetracycline, was present in the stroma of
the tumour (Fig. 8). This was found to be the lipofuscin pigment noted in the
stained sections.
Mammary Tumourrs
These tumours developed between 6 and 16 weeks from the beginning of the
course of DMBA and were studied about 2 to 3 weeks later, by which time they
had grown to between 2 and 3 cm. in diameter. In some animals tumours
developed in more than one mammary gland. The consistency of the tumours
was in general firm although there were small areas of softening. The cut surface
was greyish-white in colour.
Histologically the tumours had the structure of adenocarcinomas but there
was considerable variation in the degree ofdifferentiation even in the same tumour
(Fig. 9). In the more highly differentiated parts there were tubules lined by a
single layer of columnar epithelium in which there were only occasional mitoses.
These tubules were separated by a stroma containing spindle-shaped cells and
chronic inflammatory cells. In some parts of these areas a " comedo " pattern
could be seen.
In less differentiated areas tubule formation was still seen but the acini were
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lined by several layers of cells which varied in type from tall colunmar to flattened
epithelium. Mitoses were relatively common in this epithelium. There was
much less stroma between the tubules.
Other areas were more anaplastic with solid sheets of cells in which there
were many mitotic figures.
Areas of necrosis of variable extent were present in all the tumours and were
particularly marked in the less differentiated ones (Fig. 10).
Tetracycline studies
There was a diffuse low uptake oftetracycline by the tumour cells, comparable
with the amount found in normal epithelial cells of the mammary gland. There
did not appear to be any difference in the amount of tetracycline taken up by
tumour cells of varying degrees of differentiation. Very little tetracycline was
taken up by the stroma. In contrast large amounts of the drug were found in
necrotic areas of the tumours. Here the tetracycline was seen to be in the cyto-
plasm ofnecrotic tumour cells but the appearances varied depending on the extent
of the histological chaiiges. In cells which had lost their nuclei but whose cyto-
plasm had not become very dense there were large clumps of tetracycline. On
the other hand where the tumour cells were shrunken and had begun to disintegrate
they were often admixed with the remains of polymorphs and macrophages,
and here the tetracycline appeared to be scattered in and amongst the cells in a
fine powder. The powdery appearance was also seen in the inspissated eosino-
philic material which filled the acini in the " comedo " type of tumour.
Tetracycline was retained in these necrotic areas for at least four weeks
(Fig. 11). There was no retention of the drug by live tumour cells.
Leuklaenia
Some of the rats treated with DM1BA by stomach tube became very anaemic.
Peripheral blood films were found to contain large numbers of immature white
blood cells of the type found in stem cell leukaemia.
At post-mortem examination the liver and spleen were grossly enlarged anid
there was obvious enlargement oflymph nodes. In occasional animals the kidneys
contained discrete nodules of tumour tissue 1-2 mm. in diameter.
Histologically there was a diffuse infiltration of the liver by immature white
blood cells which had replaced the normal liver parenchyma in some areas (Fig. 12).
The normal structure of the spleen and of the lymph glands was destroyed by an
extensive infiltration with leukaemic cells. In the kidney the discrete nodules
were found to be composed of masses of leukaemic cells which had completely
replaced the normal tissues. Microscopic foci of leukaemic cells were also found
in the cortex of the adrenal glands.
Tetrcyc(cline studies
There was no uptake of tetracycline by the leukaemic cells either in the peri-
pheral blood or in the liver, spleen, kidney or adrenal glands. The areas containiing
leukaemic deposits in the liver and kidney appeared dark against the bright
fluorescence caused by the presence of high concentrations of tetracycline in the
normal tissues of these organs.
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Experimentally Produced Necrosis in Turnours
It appears from the above observations that tetracycline is taken up by
necrotic tumour cells and necrotic debris in the tumours. For this reason further
studies were carried out on the mammary tumours after attempts had been made
to increase the amount of necrosis in the tumours.
Methods. Small tumours about 0-7 cm. in diameter were selected for these
experimeiits as these tumours have been found to have undergone little if any
necrosis and consequently only take up small amounts oftetracycline. Two types
of experiments were carried out.
(a) The tumour was dissected at operation and a temporary ligature tied
around its main blood vessels. In some animals the ligature was removed after
one hour while in others it was left in place for 2 hours. Tetracycline was given
at 24 hours and the animals were killed one hour later.
(b) The tumour was removed at operation and a small piece of it was trains-
planted into the spleen of the same or another animal. Tetracycline was given at
10 days and the animals were killed one hour later.
Results. In stained sections there were areas ofnecrosis ofvarying sizes in the
ligated tumours. The greater part of the transplanted pieces of tumour were
also necrotic although some of the cells at the edge were still alive. Some of the
large necrotic areas had the typical appearances of large inifarcts with a central
dead area and the usual margin zones (Sheehan and Davis, 1958). Smaller necrotic
areas were composed only of margin zones.
The tetracycline had been taken up by the necrotic tumour cells in the margin
zones of the large infarcts but not in the central dead area. In the smaller lesions
it was seen in the necrotic tumour cells throughout the area of necrosis. The
exact appearances varied as in the spontaneous necroses described previously,
but usually it was present as large clumps in the necrotic tumour cells.
Comment. It is clear from these experiments that tumour cells which under
normal circumstances do not take up large amounts of tetracycline do so when
they undergo necrosis. The failure of the necrotic tumour cells in the central
dead areas of large infarcts to take up tetracycline is explicable because this area
does not have a circulation and is not subject to diffusion (Carroll and Tapp, 1965).
DISCUSSION
The most constant feature in these studies was the high uptake of tetracycline
by necrotic tumour cells and other debris. The drug was retained in these areas
for at least 4 weeks. The live tumour cells took up only the same amounts as
normal tissues and did not retain it for more than 24 hours. This applied to all
the tumour cells irrespective of their degree of differentiation.
Rall et al. (1957), McLeay (1958) and Phillips et al. (1960) reported that tetra-
cycline appeared to be taken up by live tumour tissue and not by the necrotic or
haemorrhagic parts, but their observations were based only on macroscopic
examination. More recently McLeay and Walske (1962) have reported that
preliminary microscopic studies indicate that tetracycline is localised in the
cytoplasm oflive tumour cells, but they do not give any details ofthe methods they
used. Their results are not in agreement with the present findings.
The possible diagnostic and therapeutic uses oftetracycline uptake by tumours
have been discussed recently by Berk (1963). As tetracycline was considered to
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be localised in the live tumour cell it was suggested that tetracycline might be
of value in distinguishing between normal and neoplastic areas especially at easily
accessible sites in the body. Lipnik (1963) applied a solution of dimethylchlor-
tetracycline to various skin lesions, and found that they all took up the substance.
When he then treated the area with trichloracetic acid the substance was removed
from benign lesions but not from malignant lesionswhich thus remained fluorescent.
He did however report false positive results in cases ofbenign tumours which were
inflamed and in crusted and healing lesions of impetigo. Cholewa, Konturek
and Groski (1963) administered tetracycline systemically to patients with tuniours
of the cervix and lip, and were able to detect the drug in the tumours by macro-
scopic inspection in ultra-violet light. In view ofthe present findings it is unlikely
that these local or general techniques show anything more than the presence of
necrosis in tumours.
Tetracycline has been found to persist longer in the gastric contents ofpatients
with carcinoma ofthe stomach than in patients with benign lesions ofthe stomach
and in normal control persons. Klinger and Katz (1961) Berk and Kantor (1962)
Sandlow, Allen and Necheles (1963) and Sherman, Chryssanthou, Sukoff, Minin-
berg, Beckman and Weingarten (1963) said that this test was of diagnostic value
for malignant lesions of the stomach but Aberle (1963), Rugtveit and Hope (1964)
and Cummins, Gompertz and Kier (1964) have reported a large number of false
positive tests in patients with benign lesions of the stomach. It is clear from the
present study that benign lesions such as chronic gastric ulcers with areas of
necrosis might well retain tetracycline and thus give false positive results.
The urinary excretion oftetracycline following a single dose has been reported
to be prolonged in patients with carcinoma (Cholewa et al., 1963; Morador, 1963)
and this has been suggested as a diagnostic test. When the non-specific nature of
tetracycline fixation to necrotic tissue is considered, such a test may be merely a
measure of the amount of necrotic tissue in the body.
Any drug which localises in tumour tissue has possible therapeutic applications,
and certain workers have therefore combined tetracycline with radioactive
substances for the treatment of experimental tumours (Dunn, Eskelson, McLeay,
Ogborn and Walske, 1960; Phillips et al., 1960). McLeay, Walske and Ogborn
(1960) found good uptake ofan l3lJ labelled tetracycline compound in spontaneous
mammary tumours in mice, and considered that the radioactive compound resulted
in necrosis of these tumours. The present work suggests that the uptake will
only occur in tumours which have areas of necrosis before the treatment is
instituted.
The uptake of tetracycline by necrotic cells of tumours is in keeping with the
findings in pathological conditions of the liver and kidney. In these organs, cells
which had become necrotic due to experimental ischaemia or toxic chemicals were
found to take up tetracycline in large amounts and to retain it for considerably
longer than the normal cells (Tapp, Carroll and Kovacs, 1964; Carroll and Tapp,
1965). In the necrotic areas of the liver after thioacetamide or carbon tetra-
chloride poisoning there are large amounts of calcium and the tetracycline
accumulation in such necrotic areas is closely related to its calcium content (Tapp
and Carroll, 1965). It has been known for some years that necrotic areas in
tumours also contain much higher concentrations of calcium than live tumour
tissue (Shear, 1933,; Suntzeff and Carruthers, 1944) and it is possible that this in
a similar way may account for the accumulation of tetracycline in such areas.
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It was observed in the squamous tumours that keratin became labelled with
tetracycline in much the same way as bone. This finding is of interest in view of
the report that tetracycline is present in the finger nails of chronic bronchitics
treated with the drug for long periods (Douglas, 1963).
SUMMARY
The uptake and retention of tetracycline was studied in a number ofdifferent
types of experimental tumours including stem cell leukaemia.
The tetracycline was taken up in large amounts by necrotic tumour tissue
and was retained there for a long period. The uptake and retention by live
tumour cells was comparable to that in normal tissues.
When necrosis was produced in growing tumours by temporary ligature of the
blood supply or transplantation to the spleen, there was a greater uptake of tetra-
cycline localised to the areas of necrosis.
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